New JerseyRevises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Jul 8Approved P.L.2026, c.40.Became Law
- Jun 30Passed Senate (Passed Both Houses) (38-2)Passed 2nd Chamber
- Jun 30Substituted for S4194/4210 (SCS)
- Jun 30Received in the Senate without Reference, 2nd ReadingMinor
- Jun 30Passed by the Assembly (76-2-1)Passed 1st Chamber
- Jun 23Reported from Assembly Comm. as a Substitute, 2nd ReadingMinor
- Jun 23Transferred to Assembly State and Local Government CommitteeMinor
- May 4Introduced, Referred to Assembly Health CommitteeIntroduced